+86-571-8627 3270
JARI Pharmaceutical Co.,Ltd.
20 YRS
Jiangsu, China
CNY 100 Million
166500 m²
100-500 people
Main Products: Gemcitabine Hydrochloride / Imatinib Mesylate / Bicalutamide / Irinotecan Hydrochloride / Fludarabine Phosphate / Pemetrexed Disodium / Torasemide / Pyridoxal 5'-Phosphate / Sulbutiamine / Levomefolate Calcium / β-Nicotinamide Mononucleotide / (2S)-1-N-(2-Aminoethyl)-3-(4-Ethoxyphenyl)Propane-1,2-Diamine,Trihydrochloride / " (S)-4-oxo-4,6,7,8-Tetrahydropyrrolo[1,2-a]Pyrimidine-6-Carboxylic acid Hydrochloride" / (2S,5R)-Ethyl 5-((Benzyloxy)Amino)Piperidine-2-Carboxylate Oxalate / 3,4-Dihydrobenzo[f][1,4]Thiazepin-5(2H)-one / 2-Chloro-5-Fluoronicotinic Acid / 2-Chloro-5-Fluoronicotinonitrile / 1-(2-Chlorophenyl)Ethanone / Diisopropyl 3,3-Dimethoxycyclobutane-1,1-Dicarboxylate / 7,8-Difluorodibenzo[b,e]Thiepin-11(6H)-one / 2,3,4,6-Tetrakis-O-Trimethylsilyl-D-Gluconolactone / (S)-1,2-Epoxyheptane / Boc-L-Tyr(Et)-oL / tert-Butyl Ethyl(4-Formylphenethyl)Carbamate / Decitabine / Pemetrexed Disodium Hemipentahydrate / Pemetrexed Disodium Heptahydrate / Letrozole / Capecitabine / Ibrutinib / Teneligliptin Hydrobromide / Atazanavir Sulfate / Olaparib / Afatinib / Cytarabine / Donepezil / Mirabegron / Erlotinib / Idarubicin / Raltitrexed / Crizotinib / Cabozantinib / Tivozanib / Pexidartinib
Jiangsu, China
ABOUT US
JARI Pharmaceutical Co.,Ltd., founded in 2004 with a registered capital of 100 million RMB, is a high-tech enterprise specializing in R&D, manufacturing and sales of pharmaceutical intermediates, API and formulations, and belongs to the state key high-tech enterprise JARI Technology Group. There are two sites of JARI PHARMA, Songtiao and Dapu, covering an overall area of 150,000m2, with the constructions of office building, R&D center, production workshop, warehouse and supporting facilities. At present, our company can produce anti-cancer API, lyophilize powder for injection, tablets, hard capsules, small volume injections and non-anticancer API and intermediates. With an excellent R&D team and a competent management team, JARI PHARMA is one of the first pharmaceutical enterprises to pass the China new GMP certification. JARI PHARMA owns China GMP certificates, U.S. FDA cGMP certificates and PIC/S certificates and obtains dozens of patents and many honorary titles including "Jiangsu High-tech Enterprise", "Jiangsu Contract-abiding & Credit-abiding Enterprises", "Jiangsu Pilot Enterprises of Integration of Information and Industrialization", etc. With the first-class R&D system, advanced production system, complete quality management system and EHS system, JARI PHARMA is dedicated to providing high-quality drugs for the public.
Basic Information
Tax ID
913207007635748894
Country/Region
Jiangsu, China
Year Established
2004
Registered Capital
CNY 100 Million
Business Type
Manufacturing
Total Employees
100-500 people
Quality Management Certificate
ISO9001, SFDA-GMP, US-FDA, KOSHER
Total Annual Revenue
-
Enterprise Ownership
Private Owned
Is This Your Own Factory
Yes
Summary Up
Produce anti-cancer API, lyophilize powder for injection, tablets, hard capsules, small volume injections and non-anticancer API and intermediates.
PLANT LOCATION
COMPANY ALBUM
厂房大门
厂房大门
厂房大门
办公区域
办公区域
办公区域
生产车间
生产车间
公司参展
公司参展
公司活动
公司活动
公司活动
其他图片
Sign In
Please enter your email address correctly
Please enter your password
Forgot Password
OR
Join Free >